These include newer levodopa formulations and drug delivery systems, refinements in adjunctive medications, and non-dopaminergic treatment strategies. Although some are in early stages of development, these novel treatments potentially widen the available options for the management of motor symptoms allowing...
The findings, which were described by one expert as "a revolution" in the care of PPD, were presented here at the European Psychiatric Association (EPA) 2019 Congress. Better Efficacy Than Oral Meds Results showed not only that 75% of patients achieved a response and that 50% were in rem...
Data on the 19 major non-psychiatric comorbidities described in the Charlson comorbidity index during the year preceding enrolment were collected from the CCH research database19. Major comorbidities, including congestive heart failure, coronary artery disease, and cerebrovascular accident, were analyzed ...
Patients were also excluded if they (1) had hereditary and degenerative diseases of the central nervous system (ICD-9-CM: 330–337) except for PD and psychiatric disorders (ICD-9-CM: 290–295); (2) had traumatic brain injury (ICD-9-CM: 800–804 and 850–854), which increases PD ...
[i.e., private residence, board/care, assisted living, or group home], another nursing home or swing bed, acute hospital, psychiatric hospital, inpatient rehabilitation facility, hospice, or other), rejects care (e.g., medications and bloodwork), hospice use (within the last 14 days either...
Psychotropic medication non-adherence and associated factors among adult patients with major psychiatric disorders: A protocol for a systematic review. Syst. Rev. 2018, 7, 10. [Google Scholar] [CrossRef] [PubMed] Boonstra, G.; Burger, H.; Grobbee, D.E.; Kahn, R.S. Antipsychotic ...